BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6977384)

  • 1. Non-T, non-B lymphomas are rare in childhood and associated with cutaneous tumor.
    Bernard A; Murphy SB; Melvin S; Bowman WP; Caillaud J; Lemerle J; Boumsell L
    Blood; 1982 Mar; 59(3):549-54. PubMed ID: 6977384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopathology of non-Hodgkin lymphomas.
    Huber H; Gattringer C; Knapp W; Stein H
    Klin Wochenschr; 1984 Nov; 62(21):1001-10. PubMed ID: 6392723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunologic phenotyping of cutaneous lymphomas].
    Kaudewitz P; Burg G; Smolle J; Braun-Falco O
    Hautarzt; 1986 Dec; 37(12):647-55. PubMed ID: 2880828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of common acute lymphoblastic leukemia antigen (CALLA) by lymphomas of B-cell and T-cell lineage.
    Ritz J; Nadler LM; Bhan AK; Notis-McConarty J; Pesando JM; Schlossman SF
    Blood; 1981 Sep; 58(3):648-52. PubMed ID: 6973348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Classification of non-Hodgkin's lymphomas on the basis of Morphological and immunological features shared by normal and neoplastic lymphatic cells (author's transl)].
    Stein H
    Immun Infekt; 1976 Apr; 4(2):52-69. PubMed ID: 1085745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoblastic lymphoma: an immunophenotype study of 26 cases with comparison to T cell acute lymphoblastic leukemia.
    Weiss LM; Bindl JM; Picozzi VJ; Link MP; Warnke RA
    Blood; 1986 Feb; 67(2):474-8. PubMed ID: 3080041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Ia-like antigen in lymphatic leukaemias and non-hodgkin lymphomas in correlation with other surface markers.
    Bergmann L; Mitrou PS; Cherdron T; Holloway K; Jost J; Timm V; Zerth G
    Scand J Haematol; 1982 Sep; 29(3):224-34. PubMed ID: 6983113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunopathology of cutaneous T-cell lymphomas.
    Nasu K; Said J; Vonderheid E; Olerud J; Sako D; Kadin M
    Am J Pathol; 1985 Jun; 119(3):436-47. PubMed ID: 3893149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
    Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
    Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytochemical characterisation of cutaneous lymphomas other than mycosis fungoides.
    Ralfkiaer E; Saati TA; Bosq J; Delsol G; Gatter KC; Mason DY
    J Clin Pathol; 1986 May; 39(5):553-63. PubMed ID: 3522633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic characterization of cutaneous T-cell lymphoma. Use of monoclonal antibodies to compare with other malignant T cells.
    Haynes BF; Metzgar RS; Minna JD; Bunn PA
    N Engl J Med; 1981 May; 304(22):1319-23. PubMed ID: 6971410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic and clinicopathologic features of common acute lymphoblastic leukemia antigen-positive childhood T-cell leukemia. A Pediatric Oncology Group Study.
    Dowell BL; Borowitz MJ; Boyett JM; Pullen DJ; Crist WM; Quddus FF; Russell EC; Falletta JM; Metzgar RS
    Cancer; 1987 Jun; 59(12):2020-6. PubMed ID: 2952260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic markers in non-Hodgkin's lymphoma.
    Freedman AS; Nadler LM
    Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunologic and clinicopathologic heterogeneity of cutaneous lymphomas other than mycosis fungoides.
    Wood GS; Burke JS; Horning S; Doggett RS; Levy R; Warnke RA
    Blood; 1983 Aug; 62(2):464-72. PubMed ID: 6603242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leu-M1 antigen expression in T-cell neoplasia.
    Wieczorek R; Burke JS; Knowles DM
    Am J Pathol; 1985 Dec; 121(3):374-80. PubMed ID: 3907362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of malignant and non-neoplastic cell phenotypes in highly malignant non-Hodgkin lymphomas.
    Porwit-Ksiazek A; Christensson B; Lindemalm C; Mellstedt H; Tribukait B; Biberfeld G; Biberfeld P
    Int J Cancer; 1983 Dec; 32(6):667-74. PubMed ID: 6317576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.
    Pinkus GS; Said JW
    Am J Pathol; 1979 Feb; 94(2):349-80. PubMed ID: 311589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of human T lymphocytes: II. Phenotypic difference in skin and blood malignant T-cells in cutaneous T-cell lymphoma.
    Haynes BF; Hensley LL; Jegasothy BV
    J Invest Dermatol; 1982 Apr; 78(4):323-6. PubMed ID: 6121832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and hematological heterogeneity of T-cell derived lymphoproliferative diseases.
    Brouet JC; Flandrin G
    Bull Cancer; 1977; 64(2):267-74. PubMed ID: 143976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell surface markers in leukemia: biological and clinical correlations.
    Thiel E
    Crit Rev Oncol Hematol; 1985; 2(3):209-60. PubMed ID: 3013441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.